In last trading session, Alx Oncology Holdings Inc (NASDAQ:ALXO) saw 3.21 million shares changing hands with its beta currently measuring 1.02. Company’s recent per share price level of $1.84 trading at $0.05 or 2.79% at ring of the bell on the day assigns it a market valuation of $97.05M. That closing price of ALXO’s stock is at a discount of -869.02% from its 52-week high price of $17.83 and is indicating a premium of 35.33% from its 52-week low price of $1.19. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.31 million shares which gives us an average trading volume of 823.92K if we extend that period to 3-months.

For Alx Oncology Holdings Inc (ALXO), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.57. Splitting up the data highlights that, out of 5 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 5 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of -0.39 in the current quarter.

Alx Oncology Holdings Inc (NASDAQ:ALXO) trade information

Upright in the green during last session for gaining 2.79%, in the last five days ALXO remained trading in the green while hitting it’s week-highest on Wednesday, 12/18/24 when the stock touched $1.84 price level, adding 10.24% to its value on the day. Alx Oncology Holdings Inc’s shares saw a change of -87.64% in year-to-date performance and have moved 21.85% in past 5-day. Alx Oncology Holdings Inc (NASDAQ:ALXO) showed a performance of 50.82% in past 30-days. Number of shares sold short was 7.17 million shares which calculate 8.58 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 23 to the stock, which implies a rise of 92.0% to its current value. Analysts have been projecting 14 as a low price target for the stock while placing it at a high target of 38. It follows that stock’s current price would drop -660.87% in reaching the projected high whereas dropping to the targeted low would mean a loss of -660.87% for stock’s current value.

Alx Oncology Holdings Inc (ALXO) estimates and forecasts

Statistics highlight that Alx Oncology Holdings Inc is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -73.26% of value to its shares in past 6 months, showing an annual growth rate of 26.20% while that of industry is 17.30. Apart from that, the company came raising its revenue forecast for fiscal year 2024.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -50.98% during past 5 years.

Alx Oncology Holdings Inc (NASDAQ:ALXO)’s Major holders

Insiders are in possession of 1.97% of company’s total shares while institution are holding 88.21 percent of that, with stock having share float percentage of 89.98%. Investors also watch the number of corporate investors in a company very closely, which is 88.21% institutions for Alx Oncology Holdings Inc that are currently holding shares of the company. VENBIO PARTNERS LLC is the top institutional holder at ALXO for having 9.7 million shares of worth $58.49 million. And as of 2024-06-30, it was holding 19.3531 of the company’s outstanding shares.

The second largest institutional holder is FMR LLC, which was holding about 7.81 million shares on 2024-06-30. The number of shares represents firm’s hold over 15.5923 of outstanding shares, having a total worth of $47.12 million.